It is a link to move within the page

Press Release

November10, 2003

Torii Pharmaceutical Co., Ltd.
Notice Concerning Acquisition of the Company's Own Shares
Through ToSTNet-2
Torii Pharmaceutical Co., Ltd. announced the decision on the method of acquisition of its own shares in accordance with the Japanese Commercial Code Article 210, with details as follows.

1. Method of Acquisition
  Shares will be purchased at the Tokyo Stock Exchange at 8:45 on the morning of November 10, 2003 at the closing price of ¥1,718 per share as of today, November11, 2003. Transactions (closing price transaction) will be made through ToSTNeT-2, and shall not be made by other trading systems or at another time. The purchase order will be valid only at the time designated for transactions.

2. Contents of Acquisition
(1) Type of shares to be acquired: common stock
(2) Total number of shares to be acquired: 600,000 shares
(Note1) This number is final. Depending on market fluctuations and other factors, a part or all of the transaction may not be performed.
(Note2) The purchase is to be made by selling orders corresponding to the number of shares planned to be acquired.

3. Announcement of Results of Acquisition
  A related announcement will be made after the conclusion of transactions at 8:45 on the morning of July 28, 2003.

(1) Resolution at the ordinary general meeting of shareholders held on June 24, 2003
Type of shares to be acquired:
Number of share to be acquired:
Total value of shares acquired:
common stock
1,000,000 shares (maximum)
¥1,800,000,000 (maximum)
(2) Progress as of November 10, 2003
  Total number of shares acquired:
Total value of shares acquired:

It is the end of the page